Albemarle Stock Forecast, Price & News

20 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last twelve months. There are currently 3 sell ratings, 7 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Albemarle stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALB, but not buy additional shares or sell existing shares.
View analyst ratings for Albemarle or view top-rated stocks.

Wall Street analysts have given Albemarle a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Albemarle wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Albemarle is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Albemarle.

Albemarle will be holding an earnings conference call on Thursday, August 5th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 404-537-3406 with passcode "6747789".

Albemarle Co. (NYSE:ALB) released its quarterly earnings data on Tuesday, May, 4th. The specialty chemicals company reported $1.10 EPS for the quarter, topping the Zacks' consensus estimate of $0.80 by $0.30. The specialty chemicals company had revenue of $829.29 million for the quarter, compared to analyst estimates of $754.03 million. Albemarle had a net margin of 11.31% and a trailing twelve-month return on equity of 9.66%.
View Albemarle's earnings history.

Albemarle's stock was trading at $70.07 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ALB shares have increased by 135.7% and is now trading at $165.18.
View which stocks have been most impacted by COVID-19.

Albemarle announced a quarterly dividend on Tuesday, May 4th. Investors of record on Friday, June 11th will be paid a dividend of $0.39 per share on Thursday, July 1st. This represents a $1.56 annualized dividend and a dividend yield of 0.94%. The ex-dividend date of this dividend is Thursday, June 10th.
View Albemarle's dividend history.

Albemarle pays an annual dividend of $1.56 per share and currently has a dividend yield of 0.97%. Albemarle has been increasing its dividend for 27 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Albemarle is 37.86%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Albemarle will have a dividend payout ratio of 31.84% next year. This indicates that Albemarle will be able to sustain or increase its dividend.
View Albemarle's dividend history.

Albemarle issued an update on its FY 2021 earnings guidance on Wednesday, May, 26th. The company provided EPS guidance of 3.250-3.650 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.500. The company issued revenue guidance of $3.20 billion-$3.30 billion, compared to the consensus revenue estimate of $3.21 billion.

20 brokers have issued 12-month price targets for Albemarle's stock. Their forecasts range from $68.00 to $200.00. On average, they anticipate Albemarle's share price to reach $142.14 in the next year. This suggests that the stock has a possible downside of 13.9%.
View analysts' price targets for Albemarle or view top-rated stocks among Wall Street analysts.

63 employees have rated Albemarle CEO Luther C. Kissam, IV on Glassdoor.com. Luther C. Kissam, IV has an approval rating of 75% among Albemarle's employees.

Some companies that are related to Albemarle include The Sherwin-Williams (SHW), Ecolab (ECL), International Flavors & Fragrances (IFF), Celanese (CE), RPM International (RPM), Ashland Global (ASH), W. R. Grace & Co. (GRA), Balchem (BCPC), Quaker Chemical (KWR), Sensient Technologies (SXT), NewMarket (NEU), H.B. Fuller (FUL), Stepan (SCL), Minerals Technologies (MTX) and Innospec (IOSP).
View all of ALB's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), NVIDIA (NVDA), Rogers Communications (RCI) and Alibaba Group (BABA).

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.56%), Franklin Resources Inc. (6.22%), Baillie Gifford & Co. (3.96%), Primecap Management Co. CA (3.18%), Bank of New York Mellon Corp (2.12%) and Mirae Asset Global Investments Co. Ltd. (2.02%). Company insiders that own Albemarle stock include Eric Norris, John Clarence Barichivich III, Karen G Narwold, Luther C Iv Kissam, Raphael Goszcz Crawford and Scott Tozier.
View institutional ownership trends for Albemarle.

ALB stock was sold by a variety of institutional investors in the last quarter, including Putnam Investments LLC, Shapiro Capital Management LLC, Primecap Management Co. CA, Pensioenfonds Rail & OV, Payden & Rygel, KBC Group NV, Nuveen Asset Management LLC, and JPMorgan Chase & Co.. Company insiders that have sold Albemarle company stock in the last year include Eric Norris, John Clarence Barichivich III, Karen G Narwold, Luther C Iv Kissam, Raphael Goszcz Crawford, and Scott Tozier.
View insider buying and selling activity for Albemarle or view top insider-selling stocks.

ALB stock was acquired by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Robeco Schweiz AG, BlackRock Inc., Mirae Asset Global Investments Co. Ltd., Price T Rowe Associates Inc. MD, Ameriprise Financial Inc., Renaissance Technologies LLC, and Baillie Gifford & Co..
View insider buying and selling activity for Albemarle or or view top insider-buying stocks.

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALB stock can currently be purchased for approximately $165.18.

Albemarle has a market capitalization of $19.28 billion and generates $3.13 billion in revenue each year. The specialty chemicals company earns $375.76 million in net income (profit) each year or $4.12 on an earnings per share basis.

Albemarle employs 5,900 workers across the globe.

The following companies are subsidiares of Albemarle: ACI Cyprus L.L.C., Albemarle (Thailand) Co. Ltd., Albemarle Argentina SRL, Albemarle Brazil Holdings LTDA., Albemarle Care Fund, Albemarle Catalysts Company B.V., Albemarle Chemical Canada Ltd., Albemarle Chemicals (Shanghai) Company Limited, Albemarle Chemicals Ltd., Albemarle Chemicals Private Limited, Albemarle Chemicals S.A.S., Albemarle Chemicals South Africa (PTY) Ltd., Albemarle Delaware Holdings 1 LLC, Albemarle Delaware Holdings 2 LLC, Albemarle Dutch Holdings 2 B.V., Albemarle Dutch Holdings B.V., Albemarle Europe Sprl, Albemarle Finance Company B.V., Albemarle Foundation, Albemarle Germany Gmbh, Albemarle Hilfe GmbH Unterstutzungskasse, Albemarle Holdings Company Limited, Albemarle Holdings Limited, Albemarle Hungary Ltd., Albemarle Italy S.R.L., Albemarle Japan Corporation, Albemarle Japan Holdings B.V., Albemarle Knight Lux 1 Holdings Corporation, Albemarle Korea Corporation, Albemarle Limitada, Albemarle Lithium Holding Corporation, Albemarle Lithium Holding GmbH, Albemarle Lithium Pty Ltd, Albemarle Malaysia Sdn Bhd, Albemarle Management (Shanghai) Co. Ltd., Albemarle Middle East Corporation FZE, Albemarle Netherlands B.V., Albemarle New Holding GmbH, Albemarle Overseas Employment Corporation, Albemarle Quimica LTDA, Albemarle Saudi Trading Company, Albemarle Singapore PTE LTD, Albemarle Spain S.L., Albemarle Taiwan Limited, Albemarle U.S. Inc., Albemarle Vietnam Limited Liability Company, Albemarle Wodgina Pty Ltd, Albemarle de Venezuela C.A., Dynamit Nobel GmbH, Dynamit Nobel Unterstützungsfonds GmbH, Excalibur II Realty Company, Excalibur Realty Company, Foote Chile Holding Company, Foote Minera e Inversiones Ltda., Jiangxi Albemarle Lithium Co. Ltd., Jordan Bromine Company Limited, Knight Lux 1 S.à r.l., Knight Lux 2 S.à r.l., MARBL Lithium Operations Pty Ltd, Metalon Environmental Management & Solutions GmbH, PT Albemarle Chemicals Indonesia, RSG Immobilien GmbH, RT Lithium Limited, Rockwood Holdings, Rockwood Holdings Inc., Rockwood Lithium India Pvt. Ltd., Rockwood Lithium Japan K.K., Rockwood Lithium Korea LLC, Rockwood Lithium Shanghai Co. Ltd., Rockwood Lithium Taiwan Co. Ltd., Rockwood Specialties GmbH, Rockwood Specialties Group LLC, Rockwood Specialties LLC, Rockwood Specialties Limited, Sales de Magnesio Limitada, Shandong Sinobrom Albemarle Bromine Chemicals Company Limited, and Sichuan Guorun New Material Co. Ltd..

Albemarle was founded in 1994.

The official website for Albemarle is www.albemarle.com.

Albemarle is headquartered at 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209.

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]